Program + Events on Lysosomal Diseases
“WORLD” is an acronym for “We’re Organizing Research on Lysosomal Diseases”, and WORLDSymposium is now considered the premier international forum for gathering experts from around the globe who are actively involved in Basic Science, Translational Studies, and Clinical Applications for lysosomal diseases. The meeting also offers an Exhibit Hall featuring state-of-the-art medical and laboratory equipment, products, and services and the Patient Advocate Showcase.
Hybrid Virtual + Live Event
Planning for WORLDSymposium 2021 is officially underway, and the 2021 Planning Committee is taking into consideration formats that will be safe and feasible in February, 2021. In anticipation of continued progress on a global level, initial plans are in place for the 17th annual live gathering in San Diego at the Manchester Grand Hyatt Hotel. In addition, plans are underway to include an alternative virtual format to supplement the live meeting, and allow for registration for those who are unable to attend in person.
- WORLDSymposium will be publishing updates by email every two-three weeks.
- The WORLDSymposium 2021 Program and Abstracts will again be published in the February 2021 “Lysosomes” issue of Molecular Genetics and Metabolism.
- There will be a new category for abstract submissions: “COVID-19 Pandemic: SARS-CoV-2 virology, pathobiology, immunization and treatment”, How is the pandemic influencing current practice, patient care, active research, and how are clinicians and researchers responding?
The WORLDSymposium Planning Committee is looking for new ideas for WORLDSymposium 2021, and will consider any ideas which can contribute to the quality and enhance the research presentations at WORLDSymposium 2021. All ideas and feedback must be submitted no later than August 1, 2020, and all submissions will be kept confidential. Submit an idea here.
Platform and Poster Sessions
WORLDSymposium is designed for basic, translational and clinical researchers, patient advocacy groups, clinicians, and all others who are interested in learning more about the latest discoveries and the clinical investigation of these diseases. This year’s meeting is expected to attract over 2000 lyosomal disease professionals from more than 50 different countries, plus more than 40 exhibiting companies and patient advocate groups. Leading scientists from around the world will present their research findings at Platform and Poster Sessions.